196 related articles for article (PubMed ID: 33413171)
21. A case of lobar pneumonia and sepsis with death caused by invasive Klebsiella rhinoscleromatis infection.
Kumade E; Furusyo N; Takeshima N; Kishihara Y; Mitsumoto-Kaseida F; Etoh Y; Murata M; Hayashi J
J Infect Chemother; 2016 Oct; 22(10):707-11. PubMed ID: 27184935
[TBL] [Abstract][Full Text] [Related]
22. [Yersinia psuedotuberculosis septicemia in a healthy young woman].
Mashiba K; Kojima T; Ootsuka T; Kusaba T
Kansenshogaku Zasshi; 2008 Mar; 82(2):86-9. PubMed ID: 18411766
[TBL] [Abstract][Full Text] [Related]
23. Clinical and microbiological follow-up of an outbreak of Yersinia pseudotuberculosis serotype Ib.
Press N; Fyfe M; Bowie W; Kelly M
Scand J Infect Dis; 2001; 33(7):523-6. PubMed ID: 11515763
[TBL] [Abstract][Full Text] [Related]
24. Yersinia enterocolitica and pseudotuberculosis infection in children.
Waldschmidt J
Prog Pediatr Surg; 1978; 11():97-105. PubMed ID: 343179
[TBL] [Abstract][Full Text] [Related]
25. Molecular relatedness between isolates Yersinia pseudotuberculosis from a patient and an isolate from mountain spring water.
Han TH; Paik IK; Kim SJ
J Korean Med Sci; 2003 Jun; 18(3):425-8. PubMed ID: 12808333
[TBL] [Abstract][Full Text] [Related]
26. Carnobacterium inhibens isolated in blood culture of an immunocompromised, metastatic cancer patient: a case report and literature review.
Lo CK; Sheth PM
BMC Infect Dis; 2021 May; 21(1):403. PubMed ID: 33933029
[TBL] [Abstract][Full Text] [Related]
27. Novel diagnostic ELISA test for discrimination between infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.
Wielkoszynski T; Moghaddam A; Bäckman A; Broden J; Piotrowski R; Mond-Paszek R; Kozarenko A; Ny T; Wilczynska M
Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2301-2306. PubMed ID: 30238343
[TBL] [Abstract][Full Text] [Related]
28. Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model.
Garrity-Ryan LK; Kim OK; Balada-Llasat JM; Bartlett VJ; Verma AK; Fisher ML; Castillo C; Songsungthong W; Tanaka SK; Levy SB; Mecsas J; Alekshun MN
Infect Immun; 2010 Nov; 78(11):4683-90. PubMed ID: 20823209
[TBL] [Abstract][Full Text] [Related]
29. The complete genome sequence of Yersinia pseudotuberculosis IP31758, the causative agent of Far East scarlet-like fever.
Eppinger M; Rosovitz MJ; Fricke WF; Rasko DA; Kokorina G; Fayolle C; Lindler LE; Carniel E; Ravel J
PLoS Genet; 2007 Aug; 3(8):e142. PubMed ID: 17784789
[TBL] [Abstract][Full Text] [Related]
30. First case of postaneurysmal prosthetic vascular infection due to a nonsuperantigenic Yersinia pseudotuberculosis strain.
Loïez C; Carnoy C; Decoene C; Pradel E; Fichel C; Courcol R; Wallet F
J Clin Microbiol; 2010 Aug; 48(8):3024-6. PubMed ID: 20573875
[TBL] [Abstract][Full Text] [Related]
31. Yersinia enterocolitica sepsis in an adolescent with Cooley's anemia.
Chiu S; Huang YC; Su LH; Lin TY
J Formos Med Assoc; 2003 Mar; 102(3):202-4. PubMed ID: 12783140
[TBL] [Abstract][Full Text] [Related]
32. A horse and a zebra: an atypical clinical picture including Guillain-Barré syndrome, recurrent fever and mesenteric lymphadenopathy caused by two concomitant infections.
Amereller F; Lottspeich C; Buchholz G; Dichtl K
Infection; 2020 Jun; 48(3):471-475. PubMed ID: 32128685
[TBL] [Abstract][Full Text] [Related]
33. Past Endemic Izumi Fever or Yersinia pseudotuberculosis Infection Reappears Sporadically.
Suzuki S; Suzuki K; Furukawa T; Nakajima M; Sakai H
Intern Med; 2024 May; 63(9):1317-1322. PubMed ID: 37839888
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Kawasaki disease showing elevated antibody titres of Yersinia pseudotuberculosis.
Tahara M; Baba K; Waki K; Arakaki Y
Acta Paediatr; 2006 Dec; 95(12):1661-4. PubMed ID: 17129979
[TBL] [Abstract][Full Text] [Related]
35. Yersinia pseudotuberculosis septicemia and HIV.
Paglia MG; D'Arezzo S; Festa A; Del Borgo C; Loiacono L; Antinori A; Antonucci G; Visca P
Emerg Infect Dis; 2005 Jul; 11(7):1128-30. PubMed ID: 16022797
[TBL] [Abstract][Full Text] [Related]
36. [INTESTINAL FAILURE AND YERSINIA PSEUDOTUBERCULOSIS TRANSLOCATION IN THE DEVELOPMENTOF EXPERIMENTAL GENERALIZED INFECTION].
Chicherin IY; Pogorelky IP; Lundovskikh IA; Darmov IV; Gorshkov AS; Shabalina MR
Eksp Klin Gastroenterol; 2016; (3):24-31. PubMed ID: 27301139
[TBL] [Abstract][Full Text] [Related]
37. Detection, seroprevalence and antimicrobial resistance of Yersinia enterocolitica and Yersinia pseudotuberculosis in pig tonsils in Northern Italy.
Bonardi S; Bruini I; D'Incau M; Van Damme I; Carniel E; Brémont S; Cavallini P; Tagliabue S; Brindani F
Int J Food Microbiol; 2016 Oct; 235():125-32. PubMed ID: 27500659
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial therapy of sepsis and septic shock--when are two drugs better than one?
Abad CL; Kumar A; Safdar N
Crit Care Clin; 2011 Apr; 27(2):e1-27. PubMed ID: 21440195
[TBL] [Abstract][Full Text] [Related]
39. Study of effectiveness of bioluminescent reporter phage assay on Y. pseudotuberculosis strains.
Mitiashvili MR
Georgian Med News; 2013 May; (218):77-82. PubMed ID: 23787513
[TBL] [Abstract][Full Text] [Related]
40. Real-time multiplex PCR assay for detection of Yersinia pestis and Yersinia pseudotuberculosis.
Matero P; Pasanen T; Laukkanen R; Tissari P; Tarkka E; Vaara M; Skurnik M
APMIS; 2009 Jan; 117(1):34-44. PubMed ID: 19161535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
